Table 3:
Spearman correlations between percent energy from fat, inflammation, circulating tumor cells, and circulating tumor DNA in the Exercise and Colorectal Cancer Treatment (EXACT) trial (N=57)
| Soluble factor | Percent energy from fat | |||||
|---|---|---|---|---|---|---|
| Unadjusted | Adjusted (age, sex, race, cancer stage, MVPAa) | Fully adjusted (age, sex, race, cancer stage, MVPAa, VATb) | ||||
| r | 95% CI | r | 95% CI | r | 95% CI | |
| High-sensitivity c-reactive protein (hsCRP) (mg/L) | −0.04 | −0.30-0.22 | −0.007 | −0.32-0.29 | 0.006 | −0.32-0.31 |
| Interleukin-6 (IL-6) (pg/mL)c | 0.19 | −0.09-0.43 | 0.16 | −0.17-0.45 | 0.12 | −0.21-0.46 |
| Soluble interleukin-6 receptor (sIL-6r) (pg/mL)d | 0.32 | 0.06-0.53 | 0.26 | −0.03-0.51 | 0.24 | −0.04-0.50 |
| Tumor necrosis factor alpha (TNFα) (pg/mL)e | 0.23 | −0.04-0.46 | 0.16 | −0.14-0.42 | 0.06 | −0.23-0.35 |
| Soluble tumor necrosis factor alpha receptor 1 (sTNFr1) (pg/mL)f | 0.32 | 0.06-0.53 | 0.25 | −0.009-0.48 | 0.20 | −0.07-0.44 |
| Soluble tumor necrosis factor alpha receptor 2 (sTNFr2) (pg/mL)g | 0.34 | 0.09-0.55 | 0.32 | 0.06-0.55 | 0.28 | 0.02-0.51 |
| Interleukin-2 (IL-2) (pg/mL)h | 0.15 | −0.15-0.42 | 0.04 | −0.26-0.35 | 0.001 | −0.29-0.33 |
| Soluble interleukin-2 receptor alpha (sIL-2rα) (pg/mL)i | 0.29 | 0.03-0.51 | 0.24 | −0.03-0.47 | 0.20 | −0.05-0.42 |
| Interleukin-10 (IL-10) (pg/mL)j | −0.01 | −0.27-0.25 | −0.02 | −0.30-0.28 | −0.08 | −0.37-0.23 |
| Interleukin-23 (IL-23)(pg/mL)k | −0.08 | −0.33-0.18 | −0.11 | −0.39-0.21 | −0.17 | −0.44-0.15 |
| Soluble receptor for advanced glycation end-products (sRAGE) (pg/mL)l | 0.23 | −0.07-0.48 | 0.25 | −0.09-0.53 | 0.22 | −0.10-0.51 |
| Circulating tumor cells (CTCs) (cells/mL) | 0.19 | −0.09-0.43 | 0.22 | −0.03-0.46 | 0.22 | −0.03-0.47 |
| Circulating tumor DNA (ctDNA) (%) | −0.03 | −0.29-0.24 | −0.01 | −0.32-0.30 | −0.02 | −0.34-0.29 |
Moderate-to-vigorous physical activity
Visceral adipose tissue
To convert pg/mL interleukin-6 to pmol/L, multiply by 0.0481
To convert pg/mL soluble interleukin-6 receptor to pmol/L, multiply by 0.0237
To convert pg/mL tumor necrosis factor alpha to pmol/L, multiply by 0.0575
To convert pg/mL soluble tumor necrosis factor alpha receptor 1 to pmol/L, multiply by 0.0182
To convert pg/mL soluble tumor necrosis factor alpha receptor 2 to pmol/L, multiply by 0.0133
To convert pg/mL interleukin-2 to pmol/L, multiply by 0.0667
To convert pg/mL soluble interleukin-2 receptor alpha to pmol/L, multiply by 0.0403
To convert pg/mL interleukin-10 to pmol/L, multiply by 0.0556
To convert pg/mL interleukin-23 to pmol/L, multiply by 0.0169
To convert pg/mL soluble receptor for advanced glycation end-products to pmol/L, multiply by 0.0294